China's Venture Capital Market: Scale, Cycles, and Recent Recovery

China's venture and growth-equity market is really two markets stapled together: a USD-denominated market historically funded by international LPs (Sequoia, SoftBank, Tiger Global, sovereign wealth, US endowments) and an RMB-denominated market funded by domestic insurance capital, wealthy individuals, and — increasingly — local government guidance funds. Through the mid-2010s these two markets grew roughly in parallel, but their governance, LP base, and exit expectations were never identical, and the gap between them is now the single most important structural fact for a foreign investor to internalize before benchmarking anything else.

Precisely how large the 2018 peak was depends on whose count you use, which is itself an instructive fact about this market's data quality. KPMG's Enterprise Venture Pulse Report put China VC investment at $70.5 billion in 2018, up 52.9% from $46.1 billion in 2017, driven substantially by Ant Financial's $14 billion Q2 2018 round. Preqin, using a broader definition of venture-stage capital, put the same year at roughly $105 billion — within striking distance of the $111 billion Preqin attributed to the US in the same year. Both figures are correct under their respective methodologies; the gap between them is a preview of how much definitional care this market demands before any number gets used in an investment memo.

The subsequent decline was not a single event but four overlapping shocks landing within roughly 24 months of each other: the 2020–2021 domestic platform-economy regulatory campaign (antitrust action against Alibaba, the Ant Group IPO suspension, the effective shutdown of the for-profit edtech sector), zero-COVID lockdowns disrupting operations and diligence travel through 2022, the collapse of the domestic IPO window as the CSRC slowed onshore listing approvals, and — layered on top of all three — a steady withdrawal of US institutional LP appetite that hardened into policy with the August 2023 US outbound investment executive order restricting American capital from semiconductors, AI, and quantum computing investments in China.

The scale of the resulting drop is now well documented across multiple independent trackers. China VC dollar volume fell from $136.2 billion across 7,486 deals in 2021 to $69.5 billion across 6,186 deals in 2022 — roughly a 49% one-year drop in dollar terms with a far shallower 17% drop in deal count, meaning the average check size collapsed even where deal activity persisted. The decline continued into 2023 (deal value down a further 27.4% year-on-year per GlobalData) and 2024, which closed at $40.2 billion, down 36.7% from 2023. Peak-to-2024 trough, using the higher $105 billion 2018 baseline, the contraction exceeds 60%; using the more conservative $70.5 billion baseline, it is closer to 43% — either way, a decline with no precedent in any comparably sized venture market over a six-year window.

A detail easy to miss in headline totals: between 2021 and 2022, deal count fell by roughly 17% while dollar volume fell by roughly 49%. That asymmetry did not disappear in the years since — it is the clearest fingerprint of what actually happened to this market. Investors did not simply stop writing checks; they stopped writing large checks, and the mega-rounds ($100M+ single financings) that had defined the 2018 boom largely vanished from the market's composition. A foreign investor comparing 2026 China deal-count statistics to 2018 and concluding the market has 'mostly recovered' is looking at the wrong variable — deal count is a weak proxy for capital intensity in a market where the average round has shrunk this dramatically.

Since 2024, deployment has stabilized and modestly recovered, but the composition of that recovery is the part foreign investors most often miss. It is not a return of the 2018 pattern. It is overwhelmingly state-guided and RMB-denominated capital rotating into a narrow set of state priority sectors — semiconductors, AI infrastructure and foundation models, advanced manufacturing, and energy storage — often through government guidance funds (政府引导基金) that carry conditions foreign LPs do not face, such as requirements to relocate manufacturing or R&D headcount to the fund's home province (covered in depth in a related fact).

The clearest evidence that this recovery is narrow rather than broad-based: foreign investor participation, measured as the share of China venture rounds that include at least one overseas firm, fell to just 8.5% of deals in 2024 — the lowest level in over a decade, and less than half the 18% recorded as recently as 2021. A market can post a headline recovery in aggregate dollars while foreign participation keeps falling, because the recovery is being driven by a category of capital (state-guided RMB funds) that foreign investors structurally cannot access on the same terms. The AI sector's early-2026 momentum — Zhipu AI and MiniMax both completing Hong Kong IPOs within 24 hours of each other in January 2026, discussed in depth in a related fact — is real and significant, but it sits on top of this narrower foreign-participation base, not a reversal of it.

China's VC market has also become more geographically concentrated as it has contracted. Beijing (particularly the Zhongguancun and Chaoyang districts), Shanghai, and Shenzhen together account for the large majority of disclosed deal value, with Hangzhou (home to Alibaba and a dense cluster of its spin-out founders) as a persistent fourth hub, particularly for e-commerce and, increasingly, AI startups with Alibaba-adjacent lineage. This concentration has intensified rather than eased since 2021: second-tier tech hubs that saw meaningful venture activity during the 2015–2018 boom — Chengdu, Wuhan, Nanjing — have seen foreign and even much domestic institutional capital pull back toward the top four cities, partly because guidance-fund-driven capital increasingly follows already-established local government incentive infrastructure (industrial parks, tax zones, talent subsidy programs) that took years to build and that smaller cities have not replicated at the same scale.

For a foreign investor, this concentration is a practical sourcing fact as much as a market-structure one: the density of credible deal flow, experienced local counsel, and English-capable management teams remains heavily weighted toward these three or four cities, and a promising company outside them faces a real, non-trivial disadvantage in raising foreign capital regardless of its underlying quality — a dynamic worth factoring into how widely to cast a sourcing net versus how much to lean on already-networked intermediaries in the established hubs.

A contracting, more concentrated market changes the return math in ways that go beyond the headline deployment figures. Fewer active investors per deal generally means less price competition at entry, which can be genuinely favorable for a disciplined new entrant — several experienced China-focused GPs have specifically noted that entry valuations in 2023–2025 for quality companies were more reasonable than at any point since the early 2010s, precisely because the pool of competing bidders shrank faster than the pool of good companies did. The offsetting risk is on the exit side: a smaller, more concentrated market also means fewer competing strategic acquirers, a thinner IPO pipeline in any given year (as the STAR Market's 2024 pullback, discussed in a related fact, illustrates), and less secondary-market liquidity to fall back on if a primary exit route stalls. The net effect is a market that can offer better entry economics to a patient, well-networked investor while demanding a longer expected holding period and a more conservative exit-timing assumption than the 2018 playbook would have suggested.